1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key benefits to the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. CHINA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY APPLICATION
5.1. Introduction
5.2. Diabetes Patients
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Critical Patients
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
6. CHINA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY END-USER INDUSTRY
6.1. Introduction
6.2. Hospitals
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Diagnostic Centers & Clinics
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. Home Care
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Market Share Analysis
7.3. Mergers, Acquisition, Agreements, and Collaborations
7.4. Competitive Dashboard
8. COMPANY PROFILES
8.1. Ypsomed AG
8.2. Dexcom, Inc.
8.3. Abbott Laboratories
8.4. Medtronic plc
8.5. Roche Diabetes Care, Inc.
8.6. Senseonics Holdings, Inc.
8.7. Insulet Corporation
8.8. Tandem Diabetes Care, Inc.
8.9. Zhejiang POCTech Medical Technology Co., Ltd.
8.10. Biolight Meditech Co., Ltd.